Dataset 48, autumn 2020 was sent to almost 100 clinics in 35 countries. Thank you for submitting your data and for meeting the December 2020 deadline. We are deeply impressed about the level of engagement and commitment to EuroSIDA. Approximately 8,000 completed follow-up forms in the face of a pandemic which occupies us all.
We are working hard to clean and download Dataset 48 so we will be able to complete reimbursement before summer. It may be delayed, but we are pushing hard to complete it before the summer so you all will be compensated before long.
Amanda Mocroft retires after decades as EuroSIDA lead
As of January 2021, Amanda no longer works at University College London, but continues to contribute to EuroSIDA as a consultant employed by CHIP. After a lengthy tenure leading both EuroSIDA and RESPOND, Amanda will focus on the scientific work within the cohorts. The EuroSIDA Secretariat thanks Amanda for her tremendous leadership and contributions to the EuroSIDA study over the past 25 years and looks forward to continuing to collaborate with her in her new role.
Lars Peters is new study lead and Principal Investigator of EuroSIDA study
As of February 2021, Lars Peters is the new study lead and Principal Investigator of the EuroSIDA study. Lars has been involved in EuroSIDA since 2007 and looks forward to continuing the excellent collaboration with all of you as he assumes his new leadership role.
In 2019, EuroSIDA identified a new cohort with the goal to enroll 2000 participants to ensure that the study is representative of the current HIV epidemic. The inclusion criteria are the same as for RESPOND to ensure that the new participants can be included in the RESPOND data lake, as RESPOND is now the main funder of EuroSIDA. As of June 2021, approximately 1400 participants have been enrolled and the cohort remains open for enrolment at least until the end of 2021. We will make sure to notify participating sites when enrolment concludes. Thank you immensely to all sites contributing to the cohort.